Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.

Ji M, Li R, Li GM, Fan Y, Dong L, Yang J, Peng YG, Wu J.

Inflammation. 2012 Jun;35(3):871-80. doi: 10.1007/s10753-011-9388-3.

PMID:
21932058
2.

Effects and mechanism analysis of combined infusion by levosimendan and vasopressin on acute lung injury in rats septic shock.

Wang X, Ma S, Liu Y, Xu W, Li Z.

Cell Biochem Biophys. 2014 Dec;70(3):1639-45. doi: 10.1007/s12013-014-0107-1.

PMID:
25002345
3.

Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock.

Rehberg S, Ertmer C, Vincent JL, Spiegel HU, Köhler G, Erren M, Lange M, Morelli A, Seisel J, Su F, Van Aken H, Traber DL, Westphal M.

Crit Care Med. 2010 Oct;38(10):2016-23. doi: 10.1097/CCM.0b013e3181ef4694.

PMID:
20657271
4.

Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.

Simon F, Giudici R, Scheuerle A, Gröger M, Asfar P, Vogt JA, Wachter U, Ploner F, Georgieff M, Möller P, Laporte R, Radermacher P, Calzia E, Hauser B.

Crit Care. 2009;13(4):R113. doi: 10.1186/cc7959. Epub 2009 Jul 10.

5.

Vasopressin, levosimendan, and cardiovascular function in septic shock.

Russell JA.

Crit Care Med. 2010 Oct;38(10):2071-3. doi: 10.1097/CCM.0b013e3181f3dda0. No abstract available.

PMID:
20855998
6.

Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits.

Faivre V, Kaskos H, Callebert J, Losser MR, Milliez P, Bonnin P, Payen D, Mebazaa A.

Anesthesiology. 2005 Sep;103(3):514-21.

PMID:
16129976
7.

Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.

Cunha-Goncalves D, Perez-de-Sa V, Larsson A, Thörne J, Blomquist S.

Anesth Analg. 2009 Nov;109(5):1576-83. doi: 10.1213/ane.0b013e3181af40e0. Epub 2009 Aug 27.

PMID:
19713252
8.

Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock.

García-Septien J, Lorente JA, Delgado MA, de Paula M, Nin N, Moscoso A, Sánchez-Ferrer A, Perez-Vizcaino F, Esteban A.

Shock. 2010 Sep;34(3):275-80. doi: 10.1097/SHK.0b013e3181cd8c5b.

PMID:
19997054
9.

Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M.

Crit Care Med. 2001 Nov;29(11):2185-93.

PMID:
11700420
10.

Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.

Yang JJ, Wang X, Ji MH, Peng YG.

Crit Care Med. 2011 Apr;39(4):921-2; author reply 922. doi: 10.1097/CCM.0b013e318206b6c8. No abstract available.

PMID:
21613859
11.

A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.

He X, Su F, Taccone FS, Laporte R, Kjølbye AL, Zhang J, Xie K, Moussa MD, Reinheimer TM, Vincent JL.

Crit Care Med. 2016 Jan;44(1):23-31. doi: 10.1097/CCM.0000000000001380.

12.

Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P.

Intensive Care Med. 2005 May;31(5):638-44. Epub 2005 Apr 6.

PMID:
15812624
13.

Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study.

Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Carbone I, Tritapepe L, Pietropaoli P, Westphal M.

Crit Care Med. 2006 Sep;34(9):2287-93.

PMID:
16791109
14.

Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock.

Fries M, Ince C, Rossaint R, Bleilevens C, Bickenbach J, Rex S, Mik EG.

Crit Care Med. 2008 Jun;36(6):1886-91. doi: 10.1097/CCM.0b013e31817cede9.

PMID:
18496356
15.

No beneficial effects of levosimendan in acute porcine endotoxaemia.

Chew MS, Hawthorne WJ, Bendall J, Whereat S, Huang S, Ting I, Simond D, McLean A.

Acta Anaesthesiol Scand. 2011 Aug;55(7):851-61. doi: 10.1111/j.1399-6576.2011.02436.x. Epub 2011 May 16.

PMID:
21574964
16.

Role of levosimendan in sepsis and septic shock.

Pinto BB, Rehberg S, Ertmer C, Westphal M.

Curr Opin Anaesthesiol. 2008 Apr;21(2):168-77. doi: 10.1097/ACO.0b013e3282f43c56. Review.

PMID:
18443483
17.

Levosimendan in early sepsis: when good ideas give poor results.

De Backer D, Bracht H.

Anesth Analg. 2009 Nov;109(5):1367-9. doi: 10.1213/ANE.0b013e3181b9e91a. No abstract available.

PMID:
19843771
18.

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?

Rehberg S, Enkhbaatar P, Traber DL.

Crit Care. 2009;13(4):178. doi: 10.1186/cc7985. Epub 2009 Aug 14.

19.

Hemodynamic, metabolic, and organ function effects of pure oxygen ventilation during established fecal peritonitis-induced septic shock.

Hauser B, Barth E, Bassi G, Simon F, Gröger M, Oter S, Speit G, Ploner F, Möller P, Wachter U, Vogt JA, Matejovic M, Calzia E, Georgieff M, Radermacher P, Maybauer DM.

Crit Care Med. 2009 Aug;37(8):2465-9. doi: 10.1097/CCM.0b013e3181aee8ad.

PMID:
19531939
20.

Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.

Rehberg S, Ertmer C, Köhler G, Spiegel HU, Morelli A, Lange M, Moll K, Schlack K, Van Aken H, Su F, Vincent JL, Westphal M.

Intensive Care Med. 2009 Jul;35(7):1286-96. doi: 10.1007/s00134-009-1470-z. Epub 2009 Apr 10.

PMID:
19360396

Supplemental Content

Support Center